You just read:

Takeda Licenses Global Rights to Theravance Biopharma's TD-8954, a Novel 5-HT4 Agonist and Motility Agent for Gastrointestinal Motility Disorders

News provided by

Takeda Pharmaceutical Company Limited

08 Jun, 2016, 13:51 BST